Radionuclide therapy of adrenal tumors Journal Article
| Authors: | Carrasquillo, J. A.; Pandit-Taskar, N.; Chen, C. C. |
| Article Title: | Radionuclide therapy of adrenal tumors |
| Abstract: | Adrenal tumors arising from chromaffin cells will often accumulate radiolabeled metaiodobenzylguanidine (MIBG) and thus are amenable to therapy with I-131 MIBG. More recently, therapy studies have targeted the somatostatin receptors using Lu-177 or Y-90 radiolabeled somatostatin analogs. Because pheochromocytoma (PHEO)/paraganglioma (PGL) and neuroblastoma (NB), which often arise from the adrenals, express these receptors, clinical trials have been performed with these reagents. We will review the experience using radionuclide therapy for targeting PHEO/PGL and NBs. © 2012 Wiley Periodicals, Inc. |
| Keywords: | treatment response; acute granulocytic leukemia; review; drug safety; hypertension; patient selection; radiopharmaceuticals; animals; paraganglioma; metastasis; nephrotoxicity; blood toxicity; nausea; thrombocytopenia; vomiting; asthenia; myelodysplastic syndrome; neuroblastoma; dosimetry; (3 iodobenzyl)guanidine i 131; radioisotope; hypothyroidism; pheochromocytoma; radioisotope therapy; mibg; adrenal gland neoplasms; somatostatin; i-131; lutetium 177 |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 106 |
| Issue: | 5 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2012-10-01 |
| Start Page: | 632 |
| End Page: | 642 |
| Language: | English |
| DOI: | 10.1002/jso.23196 |
| PROVIDER: | scopus |
| PUBMED: | 22718415 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 October 2012" - "CODEN: JSONA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
342Pandit-Taskar -
140Carrasquillo
Related MSK Work